Which diseases should cervical cancer be differentiated from?

Cervical cancer is the most common gynecological tumor in women. The early symptoms are not obvious, mostly contact bleeding. Ultrasound examination is not specific. TCT and HPV are the first choice for cervical examination. On the basis of abnormality, colposcopy is further performed. Uterine cancer is also called endometrial cancer or uterine cancer. Second, cervical cancer requires severe cervical erosion identification and diagnosis, which can be distinguished by cervical tissue biopsy.

The latest targeted drugs for cervical cancer

There are no specific targeted drugs for cervical cancer. The treatments for patients with cervical cancer are mainly surgery, radiotherapy, and chemotherapy. For patients whose disease progresses after the above treatments, targeted drugs may be considered. At present, targeted drugs for cervical cancer include the multi-target inhibitor anlotinib and the immunotherapy inhibitors nivolumab or pembrolizumab. These targeted drugs can improve the quality of life of patients to a certain extent and prolong their survival time. However, for patients with cervical cancer, targeted drugs can also be selected for treatment. Commonly used targeted drugs can be anlotinib, nivolumab, or pembrolizumab. There are targeted drugs for cervical cancer.

How is cervical cancer treated in older adults?

The patient's case is a late-stage cervical cancer and malignant tumor. The disease is associated with Chlamydia trachomatis, herpes simplex virus type II, Trichomonas and other infections. There are often no symptoms or signs in the early stage, and vaginal bleeding and discharge may develop. The patient's case is a late-stage cervical cancer and malignant tumor. The disease is associated with Chlamydia trachomatis, herpes simplex virus type II, Trichomonas and other infections. There is no particularly effective treatment for cervical cancer, and it can only control the metastasis and spread of cancer cells.